To access this element change to forms mode OFF
Grant Award View - GA30157
Development of new therapies for COPD
GA ID:
GA30157
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2022
Value (AUD):
$886,503.60
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
Development of new therapies for COPD
Purpose:
Emphysema is a major cause of illness and death and there are no good treatments. It is caused by smoking that induces lung inflammation and disease. Cellular respiration can become defective causing oxidative stress and inflammation and we think that these may drive emphysema. We have developed new treatments that restore cell respiration and stop oxidative stress. We will assess altered respiration and oxidative stress in emphysema and stop and/or reverse these changes with our new therapies.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1156589
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Newcastle
Recipient ABN:
15 736 576 735
Grant Recipient Location
Suburb:
Callaghan
Town/City:
Callaghan
Postcode:
2308
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, UNITED KINGDOM